Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
Hosted on MSN3h
Insurance Company Where CEO Was Assassinated Jacking Up Cost of Cancer Drugs by "Thousands of Percent," Government FindsUnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...
The Arkansas Pharmacists Association and Attorney General Tim Griffin held a press conference at 10:30 a.m. Thursday ...
UnitedHealth posted a better-than-expected fourth-quarter profit, but a nagging rise in medical costs and care utilization ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
The largest pharmacy-benefit managers hiked the prices of dozens of drugs dispensed through their own pharmacies, according ...
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.
The bill is similar to Pennsylvania's new law and would curb PBMs by setting rules for rebates, audits and specialty drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback